|
CENTRIC
Cilengitide in subjects with newly diagnosed GBM and methylated MGMT
gene promoter-a Multicenter, open-label, controlled Phase III study,
testing cilengitide in combination with standard treatment (Temozolomide
with concomitant radiation therapy, followed by Temozolomide maintenance
therapy) versus standard treatment alone
MMC
Evaluation of the Use of Adaptive Fractionated Stereotactic Radiosurgery
for Spinal and Paraspinal
Tumors Using Image Guided Tomotherapy
RTOG 0825
Phase III Double Blind Placebo-Controlled Trial of Conventional
Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Vs. Conventional
Concurrent Chemoradiation and Adjuvant Temozolomide in Patients
with Newly Diagnosed Glioblastoma
[top]
Breast ECOG 2504 (TAILORx
Trial)
A Phase III Randomized Study of Adjuvant Combination Chemotherapy
and Hormonal Therapy vs. Adjuvant Hormonal Therapy Alone in Women
with Previously Resected Axillary Node-Negative Breast Cancer with
Various Levels of Risk for Recurrence
Breast
IBCSG 2402 (Suppression of Ovarian Function Trial/SOFT)
A Phase III Trial Evaluating the Role of Ovarian Function Suppression
and the Role of Exemestane Adjuvant Therapies for Premenopausal
Women with Endocrine Responsive Breast Cancer
NSABP B44
A Multicenter Phase III randomized Trial of Adjuvant Therapy for
Patients with Her-2 Positive, Node Positive or High Risk Node Negative
Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy
Plus Trastuzumab Plus Bevacizumab (BETH)
AVF 4349n
An observational study of treatment Patterns and Safety Outcomes
for Metastatic or Locally Recurrent Breast Cancer (VIRGO)
SUB-STUDY-Archival
Tissue Collection in association with Main Study
[top]
RTOG 0436
A Phase III Trial Evaluating the addition of Cetuximab to Paclitaxel,
Cisplatin, and Radiation
for Patients with Esophageal Cancer who are Treated without
Surgery
RTOG 0822
Phase II Evaluation of Preoperative Chemotherapy Utilizing Intensity
Modulated Radiation
Therapy (IMRT) in Combination with Capecitabine and Oxaliplatin
for Patients
with Locally Advanced Rectal Cancer
[top]
Prostate MMC
Phase I/II Study to Evaluate Feasibility and Validation
of Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer
at High Dose Levels
Renal Cell ECOG E2805
A Randomized Double-Blind Phase III Trial of Adjuvant Sunitinib
vs. Sorafenib vs. Placebo in Patients with Resected Renal Cell Carcinoma
[top]
[top]
RTOG 0514
Establishment of a Head and Neck Tissue Bank
[top]
Non-Small Cell Lung Cancer ACOSOG
Z4032
A Randomized Phase III Study of Sublobar Resection vs. Sublobar
Resection, plus Brachytherapy in High-Risk Patients with Non-Small
Cell Lung Cancer 3 cm or Smaller
RTOG 0617
A Randomized Phase III Comparison of Standard- Dose (60 Gy) Versus
High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and
Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB
Non-Small Cell Lung Cancer
[top]
MMC
Study of Stereotactic Body Radiotherapy for Recurrent or Metastatic
Lesions to the Lung, Liver, Spine and Viscera
MMC
Phase III Randomized Study of Calendula vs. Biafine to Prevent
Radiation-Induced Dermatitis
[ top ] |
